Anti-CTLA-4 antibody potentiates the antitumor effect of armed oncolytic virus OVM18 via enhancing intratumoral IL-18R1<sup>+</sup>CD8<sup>+</sup> T cells. [PDF]
Lin X +13 more
europepmc +1 more source
Ex vivo-generated conventional dendritic cells type 1 and type 2 from blood progenitors induce potent antigen-specific T-cell immunity. [PDF]
Cuenca-Escalona J +6 more
europepmc +1 more source
Pan-cancer single-cell atlases of mouse and human tumor-associated dendritic cells. [PDF]
Caro AA +19 more
europepmc +1 more source
Rethinking lymphodepleting preconditioning in adoptive T cell therapy for durable tumor control. [PDF]
Figueroa D, Borgna V, Lladser A.
europepmc +1 more source
Targeting Lipid Metabolic Reprogramming to Overcome Immunotherapy Resistance: Systemic Nutritional Modulation and Precision Nanomedicine. [PDF]
Li Q, Yang J, Chen D, Chen Y, Jiang S.
europepmc +1 more source
Control of poorly immunogenic tumors with systemic STING agonist-loaded liposomes targeting cross-presenting dendritic cells. [PDF]
Zeng B +11 more
europepmc +1 more source
mRNA vaccines engage unconventional pathways in CD8<sup>+</sup> T cell priming. [PDF]
Jo S +17 more
europepmc +1 more source
Plasmacytoid Dendritic Cells Exhibit High Transferrin Receptor Expression Without Iron Accumulation. [PDF]
Corkish C +7 more
europepmc +1 more source
A cDC1-NK/T-Malignant Cell Circuit Drives Immunogenic Remodeling Under PD-1 Blockade in Gastric Cancer. [PDF]
Nakatsuru T +24 more
europepmc +1 more source
Atorvastatin pre-exposure in hypercholesterolemia remedies 27HC mediated dendritic cell dysfunctions in triple-negative breast cancer. [PDF]
Choudhury PR +22 more
europepmc +1 more source

